Study to assess an immune status in small cell lung cancer patients treated with cytotoxic chemotherapy

Study to assess an immune status in small cell lung cancer patients treated with cytotoxic chemotherapy - Study to assess an immune status in small cell lung cancer patients treated with cytotoxic chemotherapy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028301

Enrollment

Registered

2017-07-20

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who are planned to be treated with chemotherapy. 2. Written study-specific informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients who are difficult to entry to this study because of psychological disorders. 2. The patients who are judged to be unsuitable by doctors.

Design outcomes

Primary

Measure	Time frame
To examine T cell balance with flow cytometry. Samples should be collected at four points, pretreatment, mid-treatment (2 and 3 or 4 weeks) and post-treatment 3 to 4 weeks later.	—

Countries

Japan

Contacts

Public ContactFuyumi Nishihara

Saitama medical university international medical center Respiratory Center

fnishi@saitama-med.ac.jp+81-42-984-4111

Outcome results